Arun Kanakkanthara - Search Results

Year	Number of Results
2009	1
2011	2
2012	4
2013	2
2014	3
2015	1
2016	4
2018	1
2019	2
2020	1
2021	3
2022	1
2023	1
2024	1

1

Marine Invertebrate Natural Products that Target Microtubules.

Miller JH, Field JJ, Kanakkanthara A, Owen JG, Singh AJ, Northcote PT. Miller JH, et al. Among authors: kanakkanthara a. J Nat Prod. 2018 Mar 23;81(3):691-702. doi: 10.1021/acs.jnatprod.7b00964. Epub 2018 Feb 12. J Nat Prod. 2018. PMID: 29431439 Review.

2

βIII-tubulin overexpression in cancer: Causes, consequences, and potential therapies.

Kanakkanthara A, Miller JH. Kanakkanthara A, et al. Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188607. doi: 10.1016/j.bbcan.2021.188607. Epub 2021 Aug 6. Biochim Biophys Acta Rev Cancer. 2021. PMID: 34364992 Review.

3

MicroRNAs: novel mediators of resistance to microtubule-targeting agents.

Kanakkanthara A, Miller JH. Kanakkanthara A, et al. Cancer Treat Rev. 2013 Apr;39(2):161-70. doi: 10.1016/j.ctrv.2012.07.005. Epub 2012 Aug 16. Cancer Treat Rev. 2013. PMID: 22902296 Review.

4

Cytoskeletal alterations that confer resistance to anti-tubulin chemotherapeutics.

Kanakkanthara A, Teesdale-Spittle PH, Miller JH. Kanakkanthara A, et al. Anticancer Agents Med Chem. 2013 Jan;13(1):147-58. Anticancer Agents Med Chem. 2013. PMID: 22583426 Review.

5

Beyond the Paclitaxel and Vinca Alkaloids: Next Generation of Plant-Derived Microtubule-Targeting Agents with Potential Anticancer Activity.

Zhang D, Kanakkanthara A. Zhang D, et al. Among authors: kanakkanthara a. Cancers (Basel). 2020 Jun 29;12(7):1721. doi: 10.3390/cancers12071721. Cancers (Basel). 2020. PMID: 32610496 Free PMC article. Review.

6

An ATM D-compartmentalization in DNA damage response.

Prasad A, Kanakkanthara A. Prasad A, et al. Among authors: kanakkanthara a. Trends Cell Biol. 2024 Mar;34(3):173-175. doi: 10.1016/j.tcb.2023.12.003. Epub 2023 Dec 29. Trends Cell Biol. 2024. PMID: 38160123

7

Peloruside A: a lead non-taxoid-site microtubule-stabilizing agent with potential activity against cancer, neurodegeneration, and autoimmune disease.

Kanakkanthara A, Northcote PT, Miller JH. Kanakkanthara A, et al. Nat Prod Rep. 2016 Apr;33(4):549-61. doi: 10.1039/c5np00146c. Epub 2016 Feb 12. Nat Prod Rep. 2016. PMID: 26867978 Review.

8

Potential role of tubulin tyrosine ligase-like enzymes in tumorigenesis and cancer cell resistance.

Das V, Kanakkanthara A, Chan A, Miller JH. Das V, et al. Among authors: kanakkanthara a. Cancer Lett. 2014 Aug 1;350(1-2):1-4. doi: 10.1016/j.canlet.2014.04.022. Epub 2014 May 6. Cancer Lett. 2014. PMID: 24814394 Review.

9

Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function.

Field JJ, Kanakkanthara A, Miller JH. Field JJ, et al. Among authors: kanakkanthara a. Bioorg Med Chem. 2014 Sep 15;22(18):5050-9. doi: 10.1016/j.bmc.2014.02.035. Epub 2014 Mar 4. Bioorg Med Chem. 2014. PMID: 24650703 Review.

10

Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian Carcinoma.

Kanakkanthara A, Hou X, Ekstrom TL, Zanfagnin V, Huehls AM, Kelly RL, Ding H, Larson MC, Vasmatzis G, Oberg AL, Kaufmann SH, Mansfield AS, Weroha SJ, Karnitz LM. Kanakkanthara A, et al. Cancer Res. 2022 Jan 15;82(2):307-319. doi: 10.1158/0008-5472.CAN-21-0732. Epub 2021 Nov 22. Cancer Res. 2022. PMID: 34810199 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

23 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year